Mediso Completes Strategic Technology Transfer with SSI
Mediso is thrilled to announce that it has successfully completed the initial phase of a major technology transfer agreement with Superconducting Systems Inc. (SSI), an established subsidiary of IMRIS. This agreement signifies a pivotal moment in Mediso's ongoing commitment to vertical integration and innovation in MRI systems development, particularly enhancing their product offerings in this competitive market.
Enhancing MRI Systems with Cryogen-Free Technology
For over a decade, Mediso has utilized SSI's fully cryogen-free superconducting magnets, which have proven essential in launching the widely recognized nanoScan® 3T and 7T MRI systems. These groundbreaking systems have raised the bar for preclinical MRI technology by eliminating the reliance on liquid helium and other cryogens, making them more accessible and sustainable.
Expanding Manufacturing Capabilities
With the first phase of the technology transfer concluded, Mediso is now energetically enhancing its manufacturing capabilities for magnets in Europe. The company is on track to ramp up full-scale production by the year-end. This development includes the integration of robust quality management systems to ensure unparalleled standards in the manufacturing process.
Future Directions in MRI Development
“This marks the last piece of the puzzle for Mediso, allowing us to completely vertically integrate our MRI products and advance our development of new MRI systems, up to 9.4T,” stated Gergo Bagamery, Director of Preclinical Product Development at Mediso. “By owning the magnet technology, we are empowered to create innovative designs across a variety of field strengths and bore sizes, providing unmatched flexibility in our offerings.”
The cutting-edge technology that has been transferred provides Mediso with access to SSI's foundational intellectual property and patented technologies specific to preclinical MRI. This will enable them to develop advanced conduction-cooled superconducting magnets with optimized bore sizes reaching up to 9.4T.
Collaboration Leads to Innovative Advances
Shahin Pourrahimi, CTO of SSI, remarked, “Our partnership with Mediso has been a testament to the effectiveness of our cryogen-free magnet technology in imaging. We are eager to witness the further evolution of this technology through this impactful transfer.”
Confidence in Global Impact
Marc Buntaine, CEO of IMRIS, expressed pride in facilitating this transition, stating, “We believe that Mediso’s manufacturing prowess and commitment to innovation will significantly enhance the global impact of this technology.” This collaboration aims to extend the benefits of MRI technology across various sectors, notably in research and clinical environments.
Conclusion: A Commitment to Integrated Imaging Solutions
This strategic development underscores Mediso's dedication to providing compact, innovative, and fully integrated imaging solutions, contributing meaningfully to the fields of research and clinical practice. The completed tech transfer not only boosts Mediso’s manufacturing capabilities but also reinforces its mission to deliver high-quality MRI systems that meet the needs of modern medical and scientific applications.
Frequently Asked Questions
What does the technology transfer with SSI involve?
The technology transfer allows Mediso to integrate SSI’s superconducting magnet technology, enhancing the capabilities and development of their MRI systems.
How will this impact the MRI systems developed by Mediso?
This will enable Mediso to create innovative systems reaching up to 9.4T, enhancing imaging quality and flexibility in design.
What are the benefits of cryogen-free MRI systems?
Cryogen-free MRI systems reduce reliance on harmful substances like liquid helium, making them more sustainable and cost-effective to operate.
What is Mediso's vision for the future of MRI technology?
Mediso aims to lead the market by implementing advanced manufacturing processes and novel designs that enhance the functionality and accessibility of MRI technology.
How does this partnership align with Mediso’s mission?
This partnership solidifies Mediso’s commitment to innovation and quality in imaging solutions, aiming to meet and exceed the expectations of their users in both research and clinical settings.
